SiriusPoint delivers solid FY2025 on specialty and new business growth

SiriusPoint has reported a strong set of full-year 2025 results, with gains driven by new business and specialty lines, as disciplined underwriting helped offset softer performance in Bermuda property with casualty strength in London and New York. 

SiriusPoint’s combined ratio for 2025 full-year held steady at 88.3%, unchanged from the same period year prior. Q425 saw a small improvement to 90.0% from 94.4% in Q424.

For full year, insurance and services gross written premium increased by 25.7% to $2.3 billion at year end 2025 compared to year end 2024, which SiriusPoint attributed to accident and health, expansion of surety within our specialties business line, and continued strategic organic and new program growth in our international business, specifically London MGAs.

Reinsurance gross written premium increased by 2.9% year on year, landing at $1.4 billion, driven by new business and organic growth in London and New York casualty, credit within specialties, and New York property, partially offset by decreases in Bermuda property, due to underlying rate decreases and growth reductions, and in Aviation.

Net income available to common shareholders rocketed up to $240 million by year-end 2025 compared to a loss of $21.3 million in the same period year prior. This was boosted by an increase in Q425 to $444 million compared to $184 in Q424.

Scott Egan (pictured), CEO, said: “The fourth quarter rounded out another very strong year for SiriusPoint. Our disciplined underwriting strategy, customer mindset, and relentless focus on delivery means we have a lot to be pleased about in 2025.

“Our top line grew 16%, we improved the quality of our underwriting earnings year-over-year by 1.5 points, grew our diluted book value per share by 28%, delivered a 49% increase in operating earnings per share over prior year, and we will reduce our leverage ratio to an all-time low of 23% by the end of February. Our operating return on equity of 16.2% has improved for the third consecutive year and, more importantly, outperformed against our 12-15% across the cycle target. Against this backdrop we are delighted to announce that over the next 12 months, we intend to repurchase $100 million of common shares.

“We enter 2026 with great momentum and determination. We are well positioned to navigate insurance market conditions, and we look forward to continuing to execute against our targets as we move closer to our ambition to becoming a best-in-class specialty underwriter. Our performance in 2025 is another important proof point for the company.

“I want to thank my colleagues for their hard work everyday and their unwavering support. These results would not be possible without their dedication and commitment.”

Did you get value from this story? Sign up to our free newsletters and get stories like this sent straight to your inbox.